DCTH
We are seeing a lot of action in this stock keep it on the radar. Delcath receives fast-track status from the U.S. FDA for high dose cancer treatment with melphalan.
DCTH CHART
DCTH CHART
Stock Market News, Breakouts, Swing Trades, Stocks in Play, Mojo plays, Position Trades, Options and Daytrades
Disclaimer: This website may include stock market analysis. Any ideas or opinions expressed by us is for informational purposes. Trade at your own financial risk as we assume no responsibility for your investing decisions in the markets.
1 Comments:
If anyone bought at the time this was posted they would have made out pretty good.
Post a Comment
<< Home